Lauren Reilley, | |
15 Mcintosh Rd, Hilton Head, SC 29926-2006 | |
(843) 338-6767 | |
Not Available |
Full Name | Lauren Reilley |
---|---|
Gender | Female |
Speciality | Marriage & Family Therapist |
Location | 15 Mcintosh Rd, Hilton Head, South Carolina |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1851082622 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Lauren Reilley, 15 Mcintosh Rd, Hilton Head, SC 29926-2006 Ph: (843) 338-6767 | Lauren Reilley, 15 Mcintosh Rd, Hilton Head, SC 29926-2006 Ph: (843) 338-6767 |
News Archive
A new study has shown that probiotics may serve as a potential therapeutic approach to bipolar disorder and other psychiatric conditions.
A new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) helps confirm that a molecule targeted by the experimental drug ibrutinib is critical for the development of chronic lymphocytic leukemia, the most common form of adult leukemia.
Among patients with diabetic kidney disease and hyperkalemia (elevated potassium levels in the blood), a potentially life-threatening condition, those who received the new drug patiromer, twice daily for four weeks, had significant decreases in potassium levels which lasted through one year, according to a study in the July 14 issue of JAMA.
Cornerstone Therapeutics Inc., a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today announced that the Company has licensed to Targacept, Inc. the worldwide rights to its nicotinic-receptor based patents and library of preclinical compounds that target the alpha-7 or other nicotinic receptors originally licensed to Cornerstone from the Feinstein Institute for Medical Research.
A new study reveals that high-grade gliomas, or brain tumors, in dogs contained more immune cells associated with suppressing immune response than low-grade gliomas.
› Verified 7 days ago